FDA Approved: UDENYCA — Supplemental Application (Accord BioPharma, Inc.)

View source ↗

Summary

FDA approved a supplemental Biologics License Application for UDENYCA (pegfilgrastim-cbqv) submitted by Accord BioPharma, Inc., expanding its approved indicatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• UDENYCA (pegfilgrastim-cbqv)

Snippet

SUPPL AP for UDENYCA (PEGFILGRASTIM-CBQV)